Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does THIOTEPA Cause Disease recurrence? 72 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Disease recurrence have been filed in association with THIOTEPA (Thiotepa). This represents 1.1% of all adverse event reports for THIOTEPA.

72
Reports of Disease recurrence with THIOTEPA
1.1%
of all THIOTEPA reports
17
Deaths
12
Hospitalizations

How Dangerous Is Disease recurrence From THIOTEPA?

Of the 72 reports, 17 (23.6%) resulted in death, 12 (16.7%) required hospitalization, and 7 (9.7%) were considered life-threatening.

Is Disease recurrence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 72 reports have been filed with the FAERS database.

What Other Side Effects Does THIOTEPA Cause?

Off label use (762) Febrile neutropenia (645) Mucosal inflammation (616) Cytomegalovirus infection (446) Product use in unapproved indication (425) Pyrexia (359) Drug ineffective (358) Acute graft versus host disease in skin (355) Acute graft versus host disease (331) Cytomegalovirus infection reactivation (325)

What Other Drugs Cause Disease recurrence?

NIRMATRELVIR\RITONAVIR (20,040) PREDNISONE (1,979) CYCLOPHOSPHAMIDE (1,689) RITUXIMAB (1,588) METHOTREXATE (1,401) DOXORUBICIN (980) VINCRISTINE (932) PREDNISOLONE (873) MYCOPHENOLATE MOFETIL (852) DEXAMETHASONE (784)

Which THIOTEPA Alternatives Have Lower Disease recurrence Risk?

THIOTEPA vs THIOTHIXENE THIOTEPA vs THROMBIN THIOTEPA vs THROMBIN HUMAN THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS THIOTEPA vs THYMOGLOBULINE

Related Pages

THIOTEPA Full Profile All Disease recurrence Reports All Drugs Causing Disease recurrence THIOTEPA Demographics